John O'Dea wins Outstanding Contribution to Medtech Award Monday, 19 December 2016 The Irish Medtech Association, the Ibec group which represents the medtech sector, recognised John O'Dea for his 25 years in the industry with the Outstanding Contribution to Medtech Award 2016. This award recognises an individual who has made a significant contribution to the development, growth and success of the medtech sector in Ireland. The recipient is selected by the Irish Medtech Association board, with the support of Enterprise Ireland and IDA Ireland, to acknowledge a person's contribution to the sector as a whole, rather than to any one company or organisation. Irish Medtech Association Director Sinead Keogh, said:"John O'Dea has been a great ambassador for Ireland's medtech community. Since he began his career as an engineer working in Digital Equipment and Puritan Bennett, he has become known as a champion for entrepreneurs, with a passion for building linkages across academic and clinical communities. His business Caradyne was acquired by Respironics in 2004, before he became founding CEO of Crospon in Galway 10 years ago. While setting-up and running his own businesses may be time consuming, he continues to generously give his time to share his experience as the Chairman of the External Advisory Board for BioInnovate Ireland, as well as a Special Advisor to the SFI CURAM Centre for Research in Medical Devices, as well as the wider medtech community." On receiving his award Crospon CEO John O'Dea highlighted the importance of supporting startups:"Ten years on at my startup Crospon, I only feel we are getting going. Building a device, building the clinical evidence base, it's a long journey. Here in Ireland the landscape for device startups continues to greatly improve with initiatives such as BioInnovate, Curam and the Health Innovation Hub providing fertile ground for new startups. I have sought to champion the issues pertinent to startups through my involvement down the years with the Irish Medtech Association (then IMDA). "As we look to develop this industry, we need to look to how companies can traverse the long journey to market. We need alternatives to Venture Capital funding, particularly, longer term sources of funding to allow us build companies that can reach the point of profitability, thrive and create employment. What keeps us going, as entrepreneurs in this industry is the shared belief that engineers and clinicians working together can change the way medicine is practiced. This is what makes working in this industry special, and I am very appreciative of the recognition for my role in this sector with the Outstanding Contribution to Medtech Award 2016."